These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8213583)

  • 61. Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Thamprasit A
    J Med Assoc Thai; 1997 Jan; 80(1):9-15. PubMed ID: 9078811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
    Keech A; Colquhoun D; Best J; Kirby A; Simes RJ; Hunt D; Hague W; Beller E; Arulchelvam M; Baker J; Tonkin A;
    Diabetes Care; 2003 Oct; 26(10):2713-21. PubMed ID: 14514569
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.
    Keilani T; Schlueter WA; Levin ML; Batlle DC
    Ann Intern Med; 1993 Feb; 118(4):246-54. PubMed ID: 8420442
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    Ridker PM; Revkin J; Amarenco P; Brunell R; Curto M; Civeira F; Flather M; Glynn RJ; Gregoire J; Jukema JW; Karpov Y; Kastelein JJP; Koenig W; Lorenzatti A; Manga P; Masiukiewicz U; Miller M; Mosterd A; Murin J; Nicolau JC; Nissen S; Ponikowski P; Santos RD; Schwartz PF; Soran H; White H; Wright RS; Vrablik M; Yunis C; Shear CL; Tardif JC;
    N Engl J Med; 2017 Apr; 376(16):1527-1539. PubMed ID: 28304242
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short term effects of pravastatin on blood pressure in hypercholesterolaemic hypertensive patients.
    O'Callaghan CJ; Krum H; Conway EL; Lam W; Skiba MA; Howes LG; Louis WJ
    Blood Press; 1994 Nov; 3(6):404-6. PubMed ID: 7704289
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.
    Tonelli M; Moyé L; Sacks FM; Kiberd B; Curhan G;
    Ann Intern Med; 2003 Jan; 138(2):98-104. PubMed ID: 12529091
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical study of the month. The LIPID study: "long-term intervention with pravastatin in ischaemic disease"].
    Scheen AJ
    Rev Med Liege; 1999 Jan; 54(1):2-3. PubMed ID: 10081301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.
    Davignon J; Roederer G; Montigny M; Hayden MR; Tan MH; Connelly PW; Hegele R; McPherson R; Lupien PJ; Gagné C
    Am J Cardiol; 1994 Feb; 73(5):339-45. PubMed ID: 8109547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the effects on quality of life and of the efficacy and tolerability of lovastatin versus pravastatin. The Quality of Life Multicenter Group.
    Weir MR; Berger ML; Weeks ML; Liss CL; Santanello NC
    Am J Cardiol; 1996 Mar; 77(7):475-9. PubMed ID: 8629587
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pravastatin experience in elderly and non-elderly patients.
    Mellies MJ; DeVault AR; Kassler-Taub K; McGovern ME; Pan HY
    Atherosclerosis; 1993 Jun; 101(1):97-110. PubMed ID: 8216507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese.
    Teramoto T; Nakaya N; Yokoyama S; Ohashi Y; Mizuno K; Nakamura H;
    J Atheroscler Thromb; 2010 Aug; 17(8):879-87. PubMed ID: 20543522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study.
    Sasaki J; Arakawa K; Iwashita M; Matsushita Y; Kono S;
    Circ J; 2003 Jun; 67(6):473-8. PubMed ID: 12808261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multi-centre study of the efficacy and safety of pravastatin in hypercholesterolaemic patients with non-insulin-dependent diabetes mellitus.
    Inoue Y; Kaku K; Okubo M; Hatao K; Hatao M; Kaneko T; Matsumura S; Ando S; Fujii S
    Curr Med Res Opin; 1994; 13(4):187-94. PubMed ID: 7882697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia.
    Partinen M; Pihl S; Strandberg T; Vanhanen H; Murtomäki E; Block G; Neafus R; Haigh J; Miettinen T; Reines S
    Am J Cardiol; 1994 May; 73(12):876-80. PubMed ID: 8184812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.
    Jacobson TA; Chin MM; Curry CL; Miller V; Papademetriou V; Schlant RC; LaRosa JC
    Arch Intern Med; 1995 Sep; 155(17):1900-6. PubMed ID: 7677557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.